hepatitis C

Aetna CEO says no decision yet on how to cover hepatitis C drugs
Yahoo/Reuters
Wed, 01/14/15 - 09:01 am
Aetna
hepatitis C
AbbVie
Gilead Sciences
Merck speeds up drug-submission plans for Hep C, lung cancer -WSJ
Yahoo/Reuters
Mon, 01/12/15 - 08:22 am
Merck
hepatitis C
non-small cell lung cancer
Keytruda
grazoprevir
elbasvir
Biotech’s Price Wars Are Just Beginning
Bloomberg
Fri, 01/9/15 - 08:01 am
biotech
AbbVie
Gilead Sciences
drug pricing
hepatitis C
Anthem selects Gilead as primary supplier of hepatitis C drugs
Yahoo/Reuters
Thu, 01/8/15 - 10:21 pm
Gilead Sciences
Anthem
hepatitis C
Bristol-Myers Squibb Has A Real Shot At A Home Run In Hepatitis C
Seeking Alpha
Thu, 01/8/15 - 08:21 am
Bristol-Myers Squibb
hepatitis C
Daklinza
Sunvepra
CVS Picks Gilead Hep C Drugs As Price War Looms
Investors.com
Mon, 01/5/15 - 04:04 pm
CVS
Gilead Sciences
Express Scripts
AbbVie
drug pricing
hepatitis C
Harvoni
Sovaldi
Why Gilead Sciences, Inc. Stock Plunged as Much as 14% in December
Motley Fool
Mon, 01/5/15 - 10:38 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
Express Scripts
hepatitis C
How 1 Tiny Hepatitis C Drug Developer Trounced Gilead Sciences, Inc. in 2014
Motley Fool
Fri, 01/2/15 - 08:26 am
hepatitis C
Gilead Sciences
Regulus
Harvoni
Sovaldi
RG-101
Does the AbbVie-Express Scripts pact signal drug-price Armageddon?
Fierce Pharma
Fri, 12/26/14 - 10:12 am
AbbVie
Gilead Sciences
Express Scripts
drug pricing
hepatitis C
Gilead Sciences Plunges for Second Day In A Row: What Wall Street's Saying
TheStreet.com
Tue, 12/23/14 - 04:21 pm
Gilead Sciences
hepatitis C
AbbVie
Viekira Pak
Express Scripts
AbbVie: Does Express Hep-C Deal Presage Other Such Discounts? Asks Credit Suisse
Barron's
Tue, 12/23/14 - 12:09 pm
AbbVie
hepatitis C
Express Scripts
Viekira Pak
Special Sale Price: Docs Divided Over Discount on AbbVie Hepatitis C Drug
WSJ Pharmalot
Tue, 12/23/14 - 09:37 am
physicians
AbbVie
Gilead Sciences
Viekira Pak
Express Scripts
hepatitis C
Fight over $1,100 hepatitis C pills awaits next move by CVS
San Jose Mercury News, CA
Tue, 12/23/14 - 09:34 am
hepatitis C
Gilead Sciences
AbbVie
Viekira Pak
CVS
Express Scripts
Gilead sees largest one-day drop since IPO
Marketwatch
Tue, 12/23/14 - 09:14 am
Gilead Sciences
hepatitis C
AbbVie
Viekira Pak
Express Scripts
Achillion Pharma Takeout Less Likely Following Subpar Hep C Drug Results
TheStreet.com
Mon, 12/22/14 - 01:14 pm
Achillion
ACH-3422
hepatitis C
M&A
The Hepatitis C Price Wars Begin: What the Express Scripts Move Means
WSJ Pharmalot
Mon, 12/22/14 - 01:06 pm
hepatitis C
Express Scripts
AbbVie
Viekira Pak
Gilead Sciences
Express Scripts gives AbbVie exclusive Hepatitis C billing
CNBC
Mon, 12/22/14 - 09:27 am
Express Scripts
AbbVie
hepatitis C
Viekira Pak
FDA approves AbbVie’s hepatitis treatment
Marketwatch
Fri, 12/19/14 - 03:58 pm
FDA
AbbVie
hepatitis C
Viekira Pak
AbbVie: Here’s How It Could Differentiate Itself From Gilead
Barron's
Thu, 12/18/14 - 04:04 pm
AbbVie
Gilead Sciences
hepatitis C
drug pricing
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Sat, 12/13/14 - 11:29 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C

Pages